Boron neutron capture therapy for cancer treatment
Purins A, Mundy L, Hiller JE
Record ID 32007000659
English
Authors' results and conclusions:
The studies identified in this prioritising summary were not of high quality and, as such, the conclusions must be taken as preliminary in nature. Despite this, the studies indicate that boron neutron capture therapy (BNCT) is a promising technology which appears to be able to safely and effectively treat very advanced and otherwise untreatable malignancies. Whether Australia has the infrastructure to support this technology is not evident and cost effectiveness data were not found.
Authors' recommendations:
BNCT is a promising technology that is rapidly advancing and improving, and may prove useful for the treatment of therapy refractive cancers. Studies, although restricted to small numbers of patients, have demonstrated an increased survival in patients. In addition, treatment with BNCT demonstrated no collateral damage to brain tissue. The Australian and New Zealand infrastructure capacity for the generation of neutrons is unclear at this current time, therefore HealthPACT recommended that this technology be monitored.
Details
Project Status:
Completed
Year Published:
2007
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Boron Compounds
- Neoplasms
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.